Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1368, 2011-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dasatinib: Pulmonary arterial hypertension: case report
Reactions Weekly, Vol. 1, Iss. 1432, 2012-01 ,pp. :
Access to resources
Recommend
Dasatinib [Sprycel] may increase the risk of pulmonary arterial hypertension (PAH)
Reactions Weekly, Vol. 1, Iss. 1374, 2011-01 ,pp. :
Dasatinib: Pulmonary hypertension: 9 case reports
Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. :
Tadalafil: In Pulmonary Arterial Hypertension
By Croxtall Jamie D. Lyseng-Williamson Katherine A.
Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. :
Terguride for pulmonary arterial hypertension
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. :